Antithrombotics prescription pattern and clinical outcomes in atrial fibrillation patients with type 2 diabetes mellitus

被引:0
|
作者
Hoo, Y. Y.
Mazlan-Kepli, W.
Habizal, N. H.
Ismail, M. I.
Wong, Y. P.
Rosnan, N. H.
Mohamed, S.
Abd Ghani, A. R.
Yusof, H. Mohd
Ramaiah, A. R. Abdullah
Selvaraj, K.
Abd Malek, A. M.
Ghapar, A. K. Abdul
机构
[1] Hosp Serdang, Kajang, Malaysia
[2] Univ Malaya, Wilayah Persekutuan Kual, Malaysia
关键词
D O I
10.1093/eurheartj/ehac779.118
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:152 / 152
页数:1
相关论文
共 50 条
  • [21] CARDIOMETABOLIC RISK FACTORS FOR ATRIAL FIBRILLATION IN TYPE 2 DIABETES MELLITUS
    Gaman, M.
    Dobrica, E. C.
    Pascu, E. G.
    Cozma, M. A.
    Epingeac, M. E.
    Gaman, A. M.
    Diaconu, C. C.
    JOURNAL OF HYPERTENSION, 2019, 37 : E96 - E96
  • [22] Electrical Remodelling Contributes to Atrial Fibrillation in Type 2 Diabetes Mellitus
    Bohne, Loryn J.
    Jansen, Hailey J.
    Moghtadaei, Motahareh
    Rose, Robert A.
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 346A - 346A
  • [23] Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in patients with atrial fibrillation and type 2 diabetes mellitus
    Oh, Y. S.
    Choi, Y.
    Kim, S. H.
    Kim, S. H.
    Park, S. Y.
    Kim, H. J.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [24] Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Specific Features of Development and Antirecurrence Therapy
    Kanorsky, S. G.
    Kanorskaya, Yu. S.
    KARDIOLOGIYA, 2010, 50 (07) : 31 - 37
  • [25] Atrial fibrillation is associated with increased mean platelet volume in patients with type 2 diabetes mellitus
    Turgut, Okan
    Zorlu, Ali
    Kilicli, Fatih
    Cinar, Ziynet
    Yucel, Hasan
    Tandogan, Izzet
    Dokmetas, Hatice Sebila
    PLATELETS, 2013, 24 (06) : 493 - 497
  • [26] Effectiveness and Safety of Apixaban versus Rivaroxaban in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus
    Chowdhury, Krishna Roy
    Michaud, Jonathan
    Yu, Oriana Hoi Yun
    Yin, Hui
    Azoulay, Laurent
    Renoux, Christel
    THROMBOSIS AND HAEMOSTASIS, 2022, 122 (10) : 1794 - 1803
  • [27] High bodyweight variability and increased risk of atrial fibrillation in patients with type 2 diabetes mellitus
    Lee, H. J.
    Choi, E. K.
    Han, K. D.
    Kim, D. H.
    Lee, E.
    Lee, S. R.
    Oh, S.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2020, 41 : 474 - 474
  • [28] Cardiovascular outcomes with SGLT2 inhibitors in patients with atrial fibrillation and type 2 diabetes
    Kim, S.
    Cho, Y.
    Suh, Y.
    Seo, D.
    Kim, Y.
    Shin, S-H
    DIABETOLOGIA, 2024, 67 : S342 - S342
  • [29] Sex, age, type of diabetes and incidence of atrial fibrillation in patients with diabetes mellitus: a nationwide analysis
    Bisson, Arnaud
    Bodin, Alexandre
    Fauchier, Gregoire
    Herbert, Julien
    Angoulvant, Denis
    Ducluzeau, Pierre Henri
    Lip, Gregory Y. H.
    Fauchier, Laurent
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [30] Antithrombotic prescription and clinical outcomes among patients with atrial fibrillation in a resource limited settings
    Magnerou, Annick Melanie
    Dzudie, Anastase
    Massi, Daniel Gams
    Mouliom, Siddick
    Kamdem, Felicite
    Mapoure, Yacouba
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 10 - 10